Barclays PLC Abiomed Inc Call Options Transaction History

Barclays PLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2020 May 13, 2020	BUY	$130.51 - $196.01 $2.53 Million - $3.8 Million	19,400 Added 6466.67%	19,700 $2.86 Million
Q4 2019 Feb 10, 2020	SELL	$159.31 - $223.54 $47,793 - $67,062	-300 Reduced 50.0%	300 $51,000
Q3 2019 Nov 14, 2019	BUY	$175.89 - $279.23 $17,589 - $27,923	100 Added 20.0%	600 $107,000
Q2 2019 Aug 14, 2019	SELL	$250.96 - $284.94 $2.48 Million - $2.82 Million	-9,900 Reduced 95.19%	500 $130,000
Q1 2019 May 15, 2019	BUY	$276.39 - $362.25 $2.74 Million - $3.59 Million	9,900 Added 1980.0%	10,400 $2.97 Million
Q4 2018 Feb 14, 2019	SELL	$281.08 - $444.25 $477,836 - $755,225	-1,700 Reduced 77.27%	500 $163,000
Q3 2018 Nov 14, 2018	BUY	$354.53 - $449.75 $319,077 - $404,775	900 Added 69.23%	2,200 $989,000
Q2 2018 Aug 14, 2018	SELL	$278.07 - $446.21 $83,421 - $133,863	-300 Reduced 18.75%	1,300 $532,000
Q1 2018 May 15, 2018	BUY	$192.49 - $295.85 $307,984 - $473,360	1,600 New	1,600 $466,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.